Literature DB >> 9847305

Influenza C virus CM2 protein is produced from a 374-amino-acid protein (P42) by signal peptidase cleavage.

S Hongo1, K Sugawara, Y Muraki, Y Matsuzaki, E Takashita, F Kitame, K Nakamura.   

Abstract

Although unspliced mRNA from influenza C virus RNA segment 6 (M gene) has a single open reading frame capable of encoding a 374-amino-acid protein (Mr, 42,000), the major polypeptide synthesized from this mRNA species is the CM2 protein, with an Mr of 18,000. The present study was performed to investigate the mechanism by which CM2 is generated from the unspliced mRNA. It was reported previously that the 374-amino-acid protein (P42) is an integral membrane protein having two internal hydrophobic domains, one of which (residues 241 to 252) is followed by two sequences (252 Ile-Thr-Ser and 257 Ala-Ser-Ala) favorable for cleavage by signal peptidase. To examine the possibility that P42 is cleaved by signal peptidase after Ser residue 254 or Ala residue 259 to yield CM2, we constructed three mutated M gene cDNAs in which either or both of the two sequences were eliminated and tested their ability to synthesize CM2 in the transfected COS cells. The results showed that CM2 synthesis was blocked completely when the second recognition motif for signal peptidase was removed. It was also found that when the mRNA transcript of the wild-type M gene was translated in vitro, P42, but not CM2, was synthesized in the absence of dog pancreas microsomal membranes, whereas CM2, in addition to a polypeptide (designated M1') slightly larger than matrix protein (M1), was synthesized in the presence of microsomes. When the same experiment was done with the transcript of the mutated M gene in which the second recognition motif was removed, synthesis of CM2 could not be seen, even in the presence of microsomes. From these results, we conclude that cleavage of P42 by signal peptidase after Ala residue 259 produces CM2, composed of the C-terminal 115 amino acids, in addition to M1', composed of the N-terminal 259 amino acids.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9847305      PMCID: PMC103806     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  15 in total

1.  SR alpha promoter: an efficient and versatile mammalian cDNA expression system composed of the simian virus 40 early promoter and the R-U5 segment of human T-cell leukemia virus type 1 long terminal repeat.

Authors:  Y Takebe; M Seiki; J Fujisawa; P Hoy; K Yokota; K Arai; M Yoshida; N Arai
Journal:  Mol Cell Biol       Date:  1988-01       Impact factor: 4.272

2.  Antigenic variation among human strains of influenza C virus detected with monoclonal antibodies to gp88 glycoprotein.

Authors:  K Sugawara; H Nishimura; F Kitame; K Nakamura
Journal:  Virus Res       Date:  1986-10       Impact factor: 3.303

3.  A new method for predicting signal sequence cleavage sites.

Authors:  G von Heijne
Journal:  Nucleic Acids Res       Date:  1986-06-11       Impact factor: 16.971

4.  Evidence that the amantadine-induced, M2-mediated conversion of influenza A virus hemagglutinin to the low pH conformation occurs in an acidic trans Golgi compartment.

Authors:  F Ciampor; P M Bayley; M V Nermut; E M Hirst; R J Sugrue; A J Hay
Journal:  Virology       Date:  1992-05       Impact factor: 3.616

5.  Influenza virus M2 protein has ion channel activity.

Authors:  L H Pinto; L J Holsinger; R A Lamb
Journal:  Cell       Date:  1992-05-01       Impact factor: 41.582

6.  Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes.

Authors:  M Kozak
Journal:  Cell       Date:  1986-01-31       Impact factor: 41.582

7.  Evidence that the matrix protein of influenza C virus is coded for by a spliced mRNA.

Authors:  M Yamashita; M Krystal; P Palese
Journal:  J Virol       Date:  1988-09       Impact factor: 5.103

8.  The synthesis of polypeptides in influenza C virus-infected cells.

Authors:  M Yokota; K Nakamura; K Sugawara; M Homma
Journal:  Virology       Date:  1983-10-15       Impact factor: 3.616

9.  Antigenic characterization of the nucleoprotein and matrix protein of influenza C virus with monoclonal antibodies.

Authors:  K Sugawara; H Nishimura; S Hongo; F Kitame; K Nakamura
Journal:  J Gen Virol       Date:  1991-01       Impact factor: 3.891

10.  Structural characteristics of the M2 protein of influenza A viruses: evidence that it forms a tetrameric channel.

Authors:  R J Sugrue; A J Hay
Journal:  Virology       Date:  1991-02       Impact factor: 3.616

View more
  13 in total

1.  Identification of a membrane targeting and degradation signal in the p42 protein of influenza C virus.

Authors:  A Pekosz; R A Lamb
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

2.  Role of the CM2 protein in the influenza C virus replication cycle.

Authors:  Takatoshi Furukawa; Yasushi Muraki; Takeshi Noda; Emi Takashita; Ri Sho; Kanetsu Sugawara; Yoko Matsuzaki; Yoshitaka Shimotai; Seiji Hongo
Journal:  J Virol       Date:  2010-11-24       Impact factor: 5.103

3.  Effect of Phosphorylation of CM2 Protein on Influenza C Virus Replication.

Authors:  Takanari Goto; Yoshitaka Shimotai; Yoko Matsuzaki; Yasushi Muraki; Ri Sho; Kanetsu Sugawara; Seiji Hongo
Journal:  J Virol       Date:  2017-10-27       Impact factor: 5.103

4.  Thogoto virus matrix protein is encoded by a spliced mRNA.

Authors:  G Kochs; F Weber; S Gruber; A Delvendahl; C Leitz; O Haller
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

5.  The influenza C virus CM2 protein can alter intracellular pH, and its transmembrane domain can substitute for that of the influenza A virus M2 protein and support infectious virus production.

Authors:  Shaun M Stewart; Andrew Pekosz
Journal:  J Virol       Date:  2011-09-14       Impact factor: 6.549

6.  Influenza C virus NS1 protein upregulates the splicing of viral mRNAs.

Authors:  Yasushi Muraki; Takatoshi Furukawa; Yoshihiko Kohno; Yoko Matsuzaki; Emi Takashita; Kanetsu Sugawara; Seiji Hongo
Journal:  J Virol       Date:  2009-12-09       Impact factor: 5.103

7.  Novel gene product of Thogoto virus segment 6 codes for an interferon antagonist.

Authors:  Kathrin Hagmaier; Stephanie Jennings; Johanna Buse; Friedemann Weber; Georg Kochs
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

8.  Identification of conserved RNA secondary structures at influenza B and C splice sites reveals similarities and differences between influenza A, B, and C.

Authors:  Lumbini I Dela-Moss; Walter N Moss; Douglas H Turner
Journal:  BMC Res Notes       Date:  2014-01-09

9.  Effect of cysteine mutations in the extracellular domain of CM2 on the influenza C virus replication.

Authors:  Yasushi Muraki; Takako Okuwa; Toshiki Himeda; Seiji Hongo; Yoshiro Ohara
Journal:  PLoS One       Date:  2013-04-04       Impact factor: 3.240

10.  Characterization of a novel influenza virus in cattle and Swine: proposal for a new genus in the Orthomyxoviridae family.

Authors:  Ben M Hause; Emily A Collin; Runxia Liu; Bing Huang; Zizhang Sheng; Wuxun Lu; Dan Wang; Eric A Nelson; Feng Li
Journal:  mBio       Date:  2014-03-04       Impact factor: 7.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.